An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS
about
sameAs
Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent eraAssessing and reporting heterogeneity in treatment effects in clinical trials: a proposalManagement of patients with unstable angina / non-ST-elevation myocardial infarction: a critical review of the 2007 ACC /AHA guidelinesRoutine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent eraA population-based evaluation of the thrombolysis in myocardial infarction risk score for unstable angina and non-ST elevation myocardial infarctionThe British Cardiac Society Working Group definition of myocardial infarction: implications for practiceRole of abciximab in the treatment of coronary artery diseaseContemporary management of acute coronary syndromeClopidogrel in the treatment of ischaemic heart diseaseAcute coronary syndromes: diagnosis and management, part IPrognostic impact of renal dysfunction in patients with acute coronary syndrome-role beyond the CHA2 DS2 -VASc score: Data from Taiwan acute coronary syndrome full spectrum registry.Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials.Use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-elevation myocardial infarction.Complementary prognostic values of ST segment deviation and Thrombolysis In Myocardial Infarction (TIMI) risk score in non-ST elevation acute coronary syndromes: Insights from the Platelet Receptor Inhibition in Ischemic Syndrome Management in PatieApplication of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population.Discrepancy between clinician and research assistant in TIMI score calculation (TRIAGED CPU)A Novel Risk Stratification Model for Patients with Non-ST Elevation Myocardial Infarction in the Korea Acute Myocardial Infarction Registry (KAMIR): Limitation of the TIMI Risk Scoring System.Clopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond.Management and outcomes of lower risk patients presenting with acute coronary syndromes in a multinational observational registry.The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients.Multimarker strategy in acute coronary syndrome--pro-multimarker.Myocardial infarction: contemporary management strategies.TIMI risk score: does it work equally well in both males and females?Dealing with heterogeneity of treatment effects: is the literature up to the challenge?The use of risk scores for stratification of non-ST elevation acute coronary syndrome patients.Explicit risk in acute coronary syndrome managementRisk stratification and timing of revascularization: which patients benefit from early versus later revascularization?The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromes.TIMI risk score underestimates prognosis in unstable angina/non-ST segment elevation myocardial infarction.Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: impact of age.TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS.Coronary artery disease: Risk stratification and patient selection for more aggressive secondary prevention.Use of thrombolysis in myocardial infarction risk score to predict bleeding complications in patients with unstable angina and non-ST elevation myocardial infarction undergoing percutaneous coronary intervention.Comparison of ischemic and bleeding risk scores in non-ST elevation acute coronary syndromesDoes Continuous ST-Segment Monitoring Add Prognostic Information to the TIMI, PURSUIT, and GRACE Risk Scores?
P2860
Q24236794-A69E3AEA-3720-42B6-B217-9D81AC8483A9Q24288920-42F5926D-151E-49B2-8C29-A3F5AAC2DA37Q24653318-580D7025-C7FC-45FC-AD81-6CA410B361F2Q26471900-F5CD9F31-762C-416C-9EDB-57E7102550BBQ28167379-61DD7A6B-105F-4B2C-8D45-46DB6CFABEC9Q28174074-8AAC84C1-C932-45D9-B5A7-8BCCA9D966A0Q28200177-D68A2D1E-3546-4CDC-89DF-A8BE2FC9CECDQ28212068-65ED24F9-AC38-43D9-8F36-CE1DF1FDBDA0Q28218576-C421DEB3-8F66-43F7-A74E-CAF58BF11D7BQ30490718-4C53984D-6DDC-4000-ABDB-1B7FE5F75D31Q31005750-0CD62160-092C-45A9-9BAC-419B112B6295Q31112168-DC9F1A18-F709-4647-98DA-A3DA9F0B2977Q33369310-90FDEA28-A424-455E-B093-00E338E674CAQ33595946-5C87BA6A-4ABA-460B-9FCC-A27A49A5C794Q34478087-14E19592-4B98-4893-8E80-939D8862654DQ35017934-C8FE5909-47F8-4E23-B88C-A76D8057B7DBQ35546171-81D7F774-E924-429A-ABA0-9AE85509CBE2Q35584682-8D4EDD08-FB63-4833-8081-E414BBC1FB3BQ35584923-6483D0BF-2299-484A-BD16-9090E8C1EC0DQ36614135-E6C70543-F833-427A-959A-01FD4A37E40CQ36799327-7CD5013D-7FE6-4CBF-83BB-557DB4DC570BQ36863859-D11A1D4A-0E3B-45DA-ADC1-FA4434FBD3DDQ37134951-026C6BCF-A93D-4788-AFF9-555A7967F18FQ37253011-FC2CA84B-A20A-4147-ADA6-5BB9ABDDA06FQ37293684-F4AF9914-37C1-4907-984A-27DC85D75E7CQ37453028-4CCD2845-6774-4F91-8366-10EDA42B79E7Q38009702-E69BA27A-FA90-493F-AA69-E5BEC4BE8870Q43012353-C5CB75FE-04BB-4DD4-BF15-F51ED73412C1Q43452448-1A8B0C99-1305-4885-AA38-475EF1F51B66Q44823803-F8ECD95D-F873-494A-B106-B9D2D81E8C9AQ46375283-04C3497D-1DF6-46B6-B542-30103209974DQ48761175-EC6325F3-0869-4B2B-AD42-C5C0AC63AE36Q50107729-A2F597B6-64AA-4F67-A546-A0343A38B8FFQ58088773-DB0C5287-7767-434E-B0BE-5CCD62BDED52Q59208809-060FBE33-6349-4C1A-888C-5DC48A8A9BF8
P2860
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
An integrated clinical approac ...... re for UA/NSTEMI in PRISM-PLUS
@ast
An integrated clinical approac ...... re for UA/NSTEMI in PRISM-PLUS
@en
An integrated clinical approac ...... re for UA/NSTEMI in PRISM-PLUS
@nl
type
label
An integrated clinical approac ...... re for UA/NSTEMI in PRISM-PLUS
@ast
An integrated clinical approac ...... re for UA/NSTEMI in PRISM-PLUS
@en
An integrated clinical approac ...... re for UA/NSTEMI in PRISM-PLUS
@nl
prefLabel
An integrated clinical approac ...... re for UA/NSTEMI in PRISM-PLUS
@ast
An integrated clinical approac ...... re for UA/NSTEMI in PRISM-PLUS
@en
An integrated clinical approac ...... re for UA/NSTEMI in PRISM-PLUS
@nl
P2093
P356
P1476
An integrated clinical approac ...... re for UA/NSTEMI in PRISM-PLUS
@en
P2093
C H McCabe
D A Morrow
E M Antman
S M Snapinn
P356
10.1053/EUHJ.2001.2738
P407
P577
2002-02-01T00:00:00Z